Financhill
Sell
39

ADAG Quote, Financials, Valuation and Earnings

Last price:
$2.95
Seasonality move :
-34.81%
Day range:
$2.94 - $3.20
52-week range:
$1.30 - $3.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,332.16x
P/B ratio:
1.78x
Volume:
118.1K
Avg. volume:
191.3K
1-year change:
45.81%
Market cap:
$139.5M
Revenue:
$103.3K
EPS (TTM):
-$0.64

Analysts' Opinion

  • Consensus Rating
    Adagene, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $8.00, Adagene, Inc. has an estimated upside of 170.27% from its current price of $2.96.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $2.96.

Fair Value

  • According to the consensus of 6 analysts, Adagene, Inc. has 170.27% upside to fair value with a price target of $8.00 per share.

ADAG vs. S&P 500

  • Over the past 5 trading days, Adagene, Inc. has underperformed the S&P 500 by -5.31% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Adagene, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Adagene, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Adagene, Inc. reported revenues of --.

Earnings Growth

  • Adagene, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Adagene, Inc. reported earnings per share of --.
Enterprise value:
226.8M
EV / Invested capital:
--
Price / LTM sales:
1,332.16x
EV / EBIT:
--
EV / Revenue:
2,193.31x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-8.22x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$613.5K
Return On Assets:
-32.79%
Net Income Margin (TTM):
-29038.58%
Return On Equity:
-56.44%
Return On Invested Capital:
-42.07%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2018-12-31 2019-12-31 2020-12-31 2019-12-31 2020-12-31
Income Statement
Revenue -- -- -- $482.5K $392.6K
Gross Profit -- -- -- -- --
Operating Income -- -- -- -$5.4M -$12.5M
EBITDA -- -- -- -$5.2M -$12.3M
Diluted EPS -- -- -- -$0.11 -$0.37
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $215.2M $175M $132.7M $98.8M --
Total Assets $217.9M $178.6M $135.3M $100.8M --
Current Liabilities $29.6M $56.5M $39M $39.5M --
Total Liabilities $31.6M $65.9M $52.5M $44.2M --
Total Equity $186.2M $112.7M $82.8M $56.6M --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2018-12-31 2019-12-31 2020-12-31 2019-12-31 2020-12-31
Cash Flow Statement
Cash Flow Operations -- -- -- -$6.4M -$8.5M
Cash From Investing -- -- -- $5.9M -$360.9K
Cash From Financing -- -- -- $53.4M $1.3M
Free Cash Flow -- -- -- -- --
ADAG
Sector
Market Cap
$139.5M
$25.5M
Price % of 52-Week High
83.85%
50%
Dividend Yield
0%
0%
Shareholder Yield
-8%
-1.62%
1-Year Price Total Return
45.81%
-18.12%
Beta (5-Year)
0.706
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $3.18
200-day SMA
Buy
Level $2.05
Bollinger Bands (100)
Buy
Level 1.59 - 2.61
Chaikin Money Flow
Buy
Level 1.5M
20-day SMA
Sell
Level $3.01
Relative Strength Index (RSI14)
Buy
Level 53.44
ADX Line
Buy
Level 28.07
Williams %R
Neutral
Level -55.9537
50-day SMA
Buy
Level $2.37
MACD (12, 26)
Buy
Level 0.22
25-day Aroon Oscillator
Buy
Level 68
On Balance Volume
Neutral
Level 10.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-4.0897)
Sell
CA Score (Annual)
Level (-1.6314)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.5698)
Sell
Piotroski F Score (Annual)
Level (2)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.

Stock Forecast FAQ

In the current month, ADAG has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The ADAG average analyst price target in the past 3 months is $8.00.

  • Where Will Adagene, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Adagene, Inc. share price will rise to $8.00 per share over the next 12 months.

  • What Do Analysts Say About Adagene, Inc.?

    Analysts are divided on their view about Adagene, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Adagene, Inc. is a Sell and believe this share price will drop from its current level to $7.00.

  • What Is Adagene, Inc.'s Price Target?

    The price target for Adagene, Inc. over the next 1-year time period is forecast to be $8.00 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is ADAG A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Adagene, Inc. is a Buy. 5 of 6 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ADAG?

    You can purchase shares of Adagene, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Adagene, Inc. shares.

  • What Is The Adagene, Inc. Share Price Today?

    Adagene, Inc. was last trading at $2.95 per share. This represents the most recent stock quote for Adagene, Inc.. Yesterday, Adagene, Inc. closed at $2.96 per share.

  • How To Buy Adagene, Inc. Stock Online?

    In order to purchase Adagene, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
54
AAOI alert for Mar 2

Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.

Buy
90
BNAI alert for Mar 2

Brand Engagement Network, Inc. [BNAI] is up 2.44% over the past day.

Sell
36
WLDN alert for Mar 2

Willdan Group, Inc. [WLDN] is down 1.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock